Amanda Ho is an investment analyst in the Global Equity Division. Her stock coverage includes small- and mid-cap health care services. She is an Investment Advisory Committee member of the Health Sciences Equity Strategy.
Amanda’s investment experience began in 2019, and she has been with T. Rowe Price since 2021, beginning in the U.S. Equity Division. Previously, she was an equity intern for the U.S. Equity Division during the summer of 2020. Prior to that, Amanda was employed by Snap, Inc., and Barclays Investment Bank as an equity synthetics sales-trading analyst.
Amanda earned an M.B.A. from the University of Pennsylvania, The Wharton School, and a B.S. in economics, with a concentration in financial economics and a minor in Asian and Mid East studies, from Duke University.
4335945